Vaxcyte Corporate Presentation

LO 5 Experienced Team, Board of Directors, and Scientific Advisors Outstanding Track Record in Vaccines and Biopharma о Andrew Guggenhime, MBA President & CFO Board of Directors Carlos Paya, MD, PhD Chair IMMUNE DESIGN Peter Hirth, PhD Plexxikon. Annie Drapeau ☐ toast moderna Michael Kamarck, PhD MERCK Wyeth Halley Gilbert NEO GENOMICS Teri Loxam SQZBIOTECH MERCK Management Team Grant Pickering, MBA CEO & Co-founder PROVENGE® (sipuleucel-T) +ZELNATE Victrio FLONASE ALLERGY RELIEF Jim Wassil, MS, MBA COO Prevnar 13 Pneumococcal 13-valent Conjugate vaccine (Diphtheria CRM Protein) BEXSERO® Meningococcal Group B Vaccine MENVEO RotaTeq Dermira Calistoga Pharmaceuticals Facet Biotech Heath Lukatch, PhD RED TREE VENTURE CAPITAL Kurt von Emster Abingworth partners in life science investing Grant Pickering Vaxcyte Jeff Fairman, PhD VP Research & Co-founder ZELNATE. T Victrió Paul Sauer, MBA SVP PD & Manufacturing Pulmozyme ●Pulmozy INHALATION SOLUTION Zinbryta (daclizumab) Harp Dhaliwal, MBA SVP Commercial Manufacturing & Supply Chain Dermira MEDIVATION Biogen Scientific Advisory Board Jeff Almond, PhD sanofi pasteur The vaccines division of sanofi-aventis Group Bill Hausdorff, PhD gsk ithin Wyeth GlaxoSmithKline Tony Ford-Hutchinson, PhD MERCK Tom Monath, MD CROZET BioPharma Emmanuel Hanon, PhD \IOME gsk GlaxoSmithKline Emmanuel Walter, MD, MPH Vaccines Duke University School of Medicine

View entire presentation